单细胞分析解析肝癌肿瘤细胞异质性及其免疫治疗意义
本综述聚焦单细胞分析在肝癌免疫治疗中的应用,强调需考虑肿瘤间及瘤内异质性以克服免疫治疗耐药。单细胞技术有助于更好定义肿瘤细胞群落、识别免疫治疗或联合治疗靶点,并可能革新对耐药机制的理解、指导药物研发,推动个性化医学进步。
要点
- 单细胞分析可解析肝癌肿瘤间及瘤内异质性,辅助识别免疫治疗靶点。
- 靶向肿瘤微环境是克服免疫治疗耐药的重要策略。
- 单细胞技术有望革新耐药机制理解并指导药物研发。
核心结论
- 单细胞分析有潜力革新对肝癌免疫治疗耐药机制的理解,并指导药物研发以推动个性化医学进步。
研究设计与样本
- 综述,聚焦单细胞分析在肝癌免疫治疗背景下的应用,包括在单细胞水平研究肝细胞癌生物学的依据。
主要发现
- 早期临床试验报告了有希望的结果,但III期临床试验的应答率欠佳。
- 后续转化研究表明靶向肿瘤微环境对克服免疫治疗耐药具有重要性。
- 在精准医学时代,考虑肿瘤间及瘤内异质性至关重要。
临床怎么用
- 考虑肿瘤间及瘤内异质性,利用单细胞分析更好定义肿瘤细胞群落并识别免疫治疗或联合治疗靶点。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Over the last decade, precision medicine and immunotherapeutic approaches have become increasingly popular in oncology. Early clinical trials reported promising results, but response rates in phase III clinical trials have been suboptimal. Knowledge gained from subsequent translational studies indicates the importance of targeting the tumour microenvironment to overcome resistance to immunotherapy. In this era of precision medicine, it is crucial to consider inter- as well as intratumoural heterogeneity. Single-cell analysis is a cutting-edge technology that enables us to better define the tumour cell community and to identify potential targets for immunotherapy or combination treatments. This review focuses on single-cell analysis in the context of immunotherapy in liver cancer, including the rationale behind studying hepatocellular carcinoma biology at a single-cell level. Single-cell technologies have the potential to revolutionise our understanding of resistance mechanisms and to guide drug discovery efforts, leading to further advances in personalised medicine.
引用
- Heinrich S, Craig AJ, Ma L, et al. Understanding tumour cell heterogeneity and its implication for immunotherapy in liver cancer using single-cell analysis. J Hepatol. 2020. PMID: 33271159. doi:10.1016/j.jhep.2020.11.036
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。